QuiaPEG Pharmaceuticals Holding AB (QUIA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.115x

Based on the latest financial reports, QuiaPEG Pharmaceuticals Holding AB (QUIA) has a cash flow conversion efficiency ratio of -0.115x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-747.00K ≈ $-80.39K USD) by net assets (Skr6.47 Million ≈ $696.28K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See QuiaPEG Pharmaceuticals Holding AB balance sheet quality to measure how much of total assets are equity-financed.

QuiaPEG Pharmaceuticals Holding AB - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how QuiaPEG Pharmaceuticals Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check QuiaPEG Pharmaceuticals Holding AB (QUIA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

QuiaPEG Pharmaceuticals Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of QuiaPEG Pharmaceuticals Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Essensys PLC LSE:ESYS	0.045x
EVRAZ plc LSE:EVR	0.085x
CROSS RIVER VENTURES CORP F:C6R	0.553x
Xeros Technology Group Plc LSE:XSG	-1.072x
SCANDION ONC. DK-0735 F:8VY	N/A
Xtract Resources PLC LSE:XTR	-0.023x
Fulcrum Metals PLC LSE:FMET	N/A
Akoustis Technologies, Inc. NASDAQ:AKTSQ	0.187x

Annual Cash Flow Conversion Efficiency for QuiaPEG Pharmaceuticals Holding AB (2008–2024)

The table below shows the annual cash flow conversion efficiency of QuiaPEG Pharmaceuticals Holding AB from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see QuiaPEG Pharmaceuticals Holding AB market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr16.35 Million ≈ $1.76 Million	Skr-10.17 Million ≈ $-1.09 Million	-0.622x	+7.61%
2023-12-31	Skr15.25 Million ≈ $1.64 Million	Skr-10.27 Million ≈ $-1.10 Million	-0.673x	+91.07%
2022-12-31	Skr2.41 Million ≈ $259.57K	Skr-18.18 Million ≈ $-1.96 Million	-7.536x	+99.18%
2021-12-31	Skr22.00K ≈ $2.37K	Skr-20.11 Million ≈ $-2.16 Million	-914.091x	-129.27%
2020-12-31	Skr71.00K ≈ $7.64K	Skr-28.31 Million ≈ $-3.05 Million	-398.704x	-22715.75%
2019-12-31	Skr-8.57 Million ≈ $-922.48K	Skr-15.11 Million ≈ $-1.63 Million	1.763x	+109.25%
2018-12-31	Skr545.00K ≈ $58.65K	Skr-10.39 Million ≈ $-1.12 Million	-19.068x	-1007.89%
2017-12-31	Skr6.04 Million ≈ $649.79K	Skr-10.39 Million ≈ $-1.12 Million	-1.721x	-1865.23%
2016-12-31	Skr18.44 Million ≈ $1.98 Million	Skr1.80 Million ≈ $193.49K	0.098x	+38.56%
2015-12-31	Skr6.92 Million ≈ $744.81K	Skr487.00K ≈ $52.41K	0.070x	-69.52%
2014-12-31	Skr6.44 Million ≈ $693.26K	Skr1.49 Million ≈ $160.02K	0.231x	-24.20%
2013-12-31	Skr7.24 Million ≈ $779.57K	Skr2.21 Million ≈ $237.40K	0.305x	+156.89%
2012-12-31	Skr9.73 Million ≈ $1.05 Million	Skr-5.21 Million ≈ $-560.57K	-0.535x	-393.31%
2011-12-31	Skr13.98 Million ≈ $1.50 Million	Skr2.55 Million ≈ $274.53K	0.183x	+18.41%
2010-12-31	Skr17.17 Million ≈ $1.85 Million	Skr2.65 Million ≈ $284.75K	0.154x	+50.57%
2009-12-31	Skr17.82 Million ≈ $1.92 Million	Skr1.82 Million ≈ $196.29K	0.102x	+92.50%
2008-12-31	Skr17.98 Million ≈ $1.93 Million	Skr956.00K ≈ $102.88K	0.053x	--

About QuiaPEG Pharmaceuticals Holding AB

ST:QUIA Sweden Biotechnology

Market Cap

$141.00K

Skr1.31 Million SEK

Market Cap Rank

#31268 Global

#739 in Sweden

Share Price

Skr0.00

Change (1 day)

-16.67%

52-Week Range

Skr0.00 - Skr0.00

All Time High

Skr464.25